Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma.

Autor: Palacka, Patrik^1,2 (AUTHOR) pal_patrick@yahoo.co.uk, Holíčková, Andrea² (AUTHOR), Roška, Jan² (AUTHOR), Makovický, Peter² (AUTHOR), Vallová, Miroslava³ (AUTHOR), Biró, Csaba³ (AUTHOR), Órásová, Eveline² (AUTHOR), Obertová, Jana¹ (AUTHOR), Mardiak, Jozef¹ (AUTHOR), Ward, Thomas A.⁴ (AUTHOR), Kajo, Karol³ (AUTHOR), Chovanec, Miroslav² (AUTHOR) miroslav.chovanec@savba.sk

Publikováno v: BMC Cancer. 9/5/2024, Vol. 24 Issue 1, p1-16. 16p.

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.

Autor: Fridrichova I; Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Kalinkova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Karhanek M; Laboratory of Bioinformatics, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Smolkova B; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Machalekova K; Department of Pathology, St. Elisabeth Cancer Institute, 81250 Bratislava, Slovakia., Wachsmannova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Nikolaieva N; Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia., Kajo K; Department of Pathology, St. Elisabeth Cancer Institute, 81250 Bratislava, Slovakia.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2020 Dec 24; Vol. 22 (1). Date of Electronic Publication: 2020 Dec 24.

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.

Autor: Cierna Z; Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Miskovska V; 1st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; St. Elisabeth Cancer Institute, Bratislava, Slovakia., Roska J; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Jurkovicova D; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Pulzova LB; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Sestakova Z; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Hurbanova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Machalekova K; St. Elisabeth Cancer Institute, Bratislava, Slovakia., Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; National Cancer Institute, Bratislava, Slovakia., Rejlekova K; St. Elisabeth Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Svetlovska D; St. Elisabeth Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, Comenius University, Bratislava, Slovakia., Kalavska K; St. Elisabeth Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, Comenius University, Bratislava, Slovakia.; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia., Kajo K; St. Elisabeth Cancer Institute, Bratislava, Slovakia., Babal P; Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Faculty Hospital with Policlinics Skalica a.s., Skalica, Slovakia., Mardiak J; St. Elisabeth Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Ward TA; Department of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK., Mego M; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, Comenius University, Bratislava, Slovakia., Chovanec M; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia. miroslav.chovanec@savba.sk.

Publikováno v: BMC cancer [BMC Cancer] 2020 Jan 06; Vol. 20 (1), pp. 17. Date of Electronic Publication: 2020 Jan 06.